Kwon-Sik Park

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Venues

Oncogene

Experimental & molecular medicine

bioRxiv : the preprint server for biology

Cancer research

University of Virginia

University of Cincinnati College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Virginia Jan 02 2013

United States

Assistant Professor :: Microbiology, Immunology, and Cancer Biology

Education History

University of Cincinnati College of Medicine

United States

PHD :: Molecular and Developmental Biology at Children's Hospital Medical Center

Chung-Ang University

South Korea

BSC :: Life Sciences

Publications

Matthew G Oser, David MacPherson, Trudy G Oliver, Julien Sage, Kwon-Sik Park
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene 43 (7) (2024)
Matthew G Oser, David MacPherson, Trudy G Oliver, Julien Sage, Kwon-Sik Park
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene (2024)
Matthew G Oser, David MacPherson, Trudy G Oliver, Julien Sage, Kwon-Sik Park
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene 43 (7) (2024)
Matthew G Oser, David MacPherson, Trudy G Oliver, Julien Sage, Kwon-Sik Park
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene (2024)
Matthew G Oser, David MacPherson, Trudy G Oliver, Julien Sage, Kwon-Sik Park
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene 43 (7) (2024)
Matthew G Oser, David MacPherson, Trudy G Oliver, Julien Sage, Kwon-Sik Park
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene 43 (7) (2024)
Matthew G Oser, David MacPherson, Trudy G Oliver, Julien Sage, Kwon-Sik Park
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene 43 (7) (2024)
Matthew G Oser, David MacPherson, Trudy G Oliver, Julien Sage, Kwon-Sik Park
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene 43 (7) (2024)
Matthew G Oser, David MacPherson, Trudy G Oliver, Julien Sage, Kwon-Sik Park
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene 43 (7) (2024)
Matthew G Oser, David MacPherson, Trudy G Oliver, Julien Sage, Kwon-Sik Park
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene 43 (7) (2024)
Matthew G Oser, David MacPherson, Trudy G Oliver, Julien Sage, Kwon-Sik Park
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene 43 (7) (2024)
Bongjun Kim, Shengzhe Zhang, Yuanjian Huang, Kyung-Pil Ko, Gengyi Zou, Jie Zhang, Sohee Jun, Kee-Beom Kim, Youn-Sang Jung, Kwon-Sik Park, Jae-Il Park
CRACD suppresses neuroendocrinal plasticity of lung adenocarcinoma. bioRxiv : the preprint server for biology (2023)
Shengzhe Zhang, Kee-Beom Kim, Yuanjian Huang, Dong-Wook Kim, Bongjun Kim, Kyung-Pil Ko, Gengyi Zou, Jie Zhang, Sohee Jun, Nicole A Kirk, Ye Eun Hwang, Young Ho Ban, Joseph M Chan, Charles M Rudin, Kwon-Sik Park, Jae-Il Park
CRACD, a gatekeeper restricting proliferation, heterogeneity, and immune evasion of small cell lung cancer. bioRxiv : the preprint server for biology (2023)
Shengzhe Zhang, Kee-Beom Kim, Yuanjian Huang, Dong-Wook Kim, Bongjun Kim, Kyung-Pil Ko, Gengyi Zou, Jie Zhang, Sohee Jun, Nicole A Kirk, Ye Eun Hwang, Young Ho Ban, Joseph M Chan, Charles M Rudin, Kwon-Sik Park, Jae-Il Park
CRACD, a gatekeeper restricting proliferation, heterogeneity, and immune evasion of small cell lung cancer. bioRxiv : the preprint server for biology (2023)
Ryan D Gentzler, Liza C Villaruz, John C Rhee, Bethany Jablonski Horton, Joseph Mock, Michael Hanley, Kyeongmin Kim, Michelle A Rudek, Mitch A Phelps, Michael A Carducci, Richard L Piekarz, Kwon-Sik Park, Timothy N J Bullock, Charles M Rudin
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399. The oncologist (2023)
Bongjun Kim, Shengzhe Zhang, Yuanjian Huang, Kyung-Pil Ko, Gengyi Zou, Jie Zhang, Sohee Jun, Kee-Beom Kim, Youn-Sang Jung, Kwon-Sik Park, Jae-Il Park
CRACD suppresses neuroendocrinal plasticity of lung adenocarcinoma. bioRxiv : the preprint server for biology (2023)
Shengzhe Zhang, Kee-Beom Kim, Yuanjian Huang, Dong-Wook Kim, Bongjun Kim, Kyung-Pil Ko, Gengyi Zou, Jie Zhang, Sohee Jun, Nicole A Kirk, Ye Eun Hwang, Young Ho Ban, Joseph M Chan, Charles M Rudin, Kwon-Sik Park, Jae-Il Park
CRACD, a gatekeeper restricting proliferation, heterogeneity, and immune evasion of small cell lung cancer. bioRxiv : the preprint server for biology (2023)
Nicole A Kirk, Kee-Beom Kim, Kwon-Sik Park
Effect of chromatin modifiers on the plasticity and immunogenicity of small-cell lung cancer. Experimental & molecular medicine 54 (12) (2022)
Kee-Beom Kim, Dong-Wook Kim, Youngchul Kim, Jun Tang, Nicole Kirk, Yongyu Gan, Bongjun Kim, Bingliang Fang, Jae-Il Park, Yi Zheng, Kwon-Sik Park
WNT5A-RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer. Cancer research 82 (22) (2022)
Nicole A Kirk, Kee-Beom Kim, Kwon-Sik Park
Effect of chromatin modifiers on the plasticity and immunogenicity of small-cell lung cancer. Experimental & molecular medicine (2022)
Kee-Beom Kim, Ashish Kabra, Dong-Wook Kim, Yongming Xue, Yuanjian Huang, Pei-Chi Hou, Yunpeng Zhou, Leilani J Miranda, Jae-Il Park, Xiaobing Shi, Timothy P Bender, John H Bushweller, Kwon-Sik Park
KIX domain determines a selective tumor-promoting role for EP300 and its vulnerability in small cell lung cancer. Science advances 8 (7) (2022)
Nicole A Kirk, Kee-Beom Kim, Kwon-Sik Park
Effect of chromatin modifiers on the plasticity and immunogenicity of small-cell lung cancer. Experimental & molecular medicine 54 (12) (2022)
Nicole A Kirk, Kee-Beom Kim, Kwon-Sik Park
Effect of chromatin modifiers on the plasticity and immunogenicity of small-cell lung cancer. Experimental & molecular medicine 54 (12) (2022)
Nicole A Kirk, Kee-Beom Kim, Kwon-Sik Park
Effect of chromatin modifiers on the plasticity and immunogenicity of small-cell lung cancer. Experimental & molecular medicine 54 (12) (2022)
Dylan L Schaff, Shambhavi Singh, Kee-Beom Kim, Matthew D Sutcliffe, Kwon-Sik Park, Kevin A Janes
Fragmentation of Small-Cell Lung Cancer Regulatory States in Heterotypic Microenvironments. Cancer research 81 (7) (2021)
Jeong-Hun Ko, Antoni Olona, Adonia E Papathanassiu, Norzawani Buang, Kwon-Sik Park, Ana S H Costa, Claudio Mauro, Christian Frezza, Jacques Behmoaras
BCAT1 affects mitochondrial metabolism independently of leucine transamination in activated human macrophages. Journal of cell science 133 (22) (2020)
Kee-Beom Kim, Youngchul Kim, Christopher J Rivard, Dong-Wook Kim, Kwon-Sik Park
FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer. Cancer research 80 (22) (2020)
Kee-Beom Kim, Colin T Dunn, Kwon-Sik Park
Recent progress in mapping the emerging landscape of the small-cell lung cancer genome. Experimental & molecular medicine 51 (12) (2019)
Deshui Jia, Arnaud Augert, Dong-Wook Kim, Emily Eastwood, Nan Wu, Ali H Ibrahim, Kee-Beom Kim, Colin T Dunn, Smitha P S Pillai, Adi F Gazdar, Hamid Bolouri, Kwon-Sik Park, David MacPherson
Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition. Cancer discovery 8 (11) (2018)

Kwon-Sik Park.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kwon-Sik Park